Vascular endothelial growth factor +936 C/T polymorphism is associated with an increased risk of endometriosis in a Japanese population

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 11, 2007, Pages 1352-1358

  Ikuhashi, Yoshiyuki ^a   Yoshida, Shigeki ^a   Kennedy, Stephen ^b   Zondervan, Krina ^c   Takemura, Naoya ^a   Deguchi, Masashi ^a   Ohara, Noriyuki ^a   Maruo, Takeshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Endometriosis; Gene polymorphism; Polymerase chain reaction; Restriction fragment length polymorphism; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPANESE; LAPAROSCOPY; LAPAROTOMY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; UNIVERSITY HOSPITAL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35649027502     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701644991     Document Type: Article

References (22)

1. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci. 2002;955:89-100.
2. Lin CC, Wu HC, Tsai FJ, Chen HY, Chen WC. Vascular endothelial growth factor gene -460 C/T polymorphism is a biomarker for prostate cancer. Urology. 2003;62:374-7.
3. Ku KT, Wan L, Peng HC, Tsai MH, Tsai CH, Tsa FJ. Vascular endothelial growth factor -460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol. 2005;41:497-502.
4. Boiardi L, Casali B, Nicoli D, Farnetti E, Chen Q, Macchioni P, et al. Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol. 2003;30:2160-4.
5. Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F, et al. Vascular endothelial growth factor gene polymorphisms in Behcet disease. J Rheumatol. 2004;31:1785-9.
6. Cooke RWI, Drury JA, Mountford R, Clark D. Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2004;45:1712-5.
7. Han SW, Kin GW, Seo JS, Kim SJ, Sa KH, Park JY, et al. VEGF polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology. 2004;43:1173-7.
8. Papazoglou D, Galazios G, Koukourakis MI, Panagopoulos I, Kontomanolis EN, Papatheodorou K, et al. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod. 2004;10:321-4.
9. Medford ARL, Keen LJ, Bidwell JL, Millar AB. Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax. 2005;60:244-8.
10. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer. 2003;106:468-71.
11. Hsieh YY, Chang CC, Tsai FJ, Yeh LS, Lin CC, Peng CT. T allele for VEGF gene-460 polymorphism at the 5?-untranslated region: association with a higher susceptibility to endometriosis. J Reprod Med. 2004;49:468-72.
12. Bhanoori M, Babu KA, Pavankumar Reddy NG, Lakshmi Rao KL, Zondervan K, Deenadayal M, et al. The vascular endothelial growth factor (VEGF) +405G>C 5′-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod. 2005;20:1844-9.
13. Kim SH, Choi YM, Choung SH, Jun JK, Kim JG, Moon SY. Vascular endothelial growth factor to gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod. 2005;20:2904-8.
14. Revised American Society for Reproductive Medicine Classification of endometriosis: 1996. Fertil Steril. 1997;67:817-21.
15. Barett JC, Fry B, Maller JD, Daly MJ. Haploviewer: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-5.
16. Holt RC, Ralph SA, Webb NJ, Watson CJ, Clark AG, Mathieson PW, et al. Steroid-sensitive nephritic syndrome and vascular endothelial growth factor gene polymorphisms. Eur J Immunogenet. 2003;30:1-3.
17. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res. 2004;56:953-9.
18. Abe A, Sato K, Habuchi T, Wang L, Li Z, Tsuchiya N, et al. Single nucleotide polymorphisms in the 3? untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med. 2002;198:181-90.
19. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2003;51:1635-9.
20. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37:443-8.
21. Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study?: design issues for complex traits such as endometriosis. Hum Reprod. 2002;17:1415-23.
22. Agrawal R, Conway GS, Sladkevevicius P, Payne NN, Bekir J, Campell S, et al. Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow. Clin Endocrinol. 1999;50:101-6.